Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: CD14+CD16 monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK

Fig. 3

The expression of Tyro3TK on CD14+CD16 monocytes is increased in RA. a Gating strategy for identifying the expression of Tyro3TK on CD14+CD16+ and CD14+CD16 monocytes. Accordingly, the expression of Tyro3TK on CD14+CD16+ and CD14+CD16 monocytes in HC (n = 40) (b), OA (n = 28) (c), and RA patients (n = 40, **P = 0.008) (d) were analyzed and presented as the mean fluorescence intensity (MFI). e The expression of Tyro3TK on CD14+CD16+ monocytes were compared between HC, OA, and RA patients. f The expression of Tyro3TK on CD14+CD16 monocytes were compared between HC, OA, and RA patients (**P = 0.004, ***P < 0.001). g Flow cytometry-sorted CD14+CD16 monocytes from RA (n = 4) and HC (n = 4) were set to detect the mRNA expression of Tyro3TK by qPCR (*P = 0.029). *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant (Mann-Whitney U test, b, d, and g; Student’s t test, c; Kruskal-Wallis test followed by Dunn’s post-test for multiple comparisons, ef)

Back to article page
\